FDA.reportPublic FDA data

remibrutinib 25 MG Oral Tablet

RxCUI
2724392
RxNorm name
remibrutinib 25 MG Oral Tablet
Display name
remibrutinib 25 MG Oral Tablet
Full name
remibrutinib 25 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:25

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e5e89bff-6ced-4165-acc5-fb13136b3a3dremibrutinib 25 MG Oral Tablet [PSN] · remibrutinib 25 MG Oral Tablet [SCD]22These highlights do not include all the information needed to use RHAPSIDO safely and effectively. See full prescribing information for RHAPSIDO. RHAPSIDO ® (remibrutinib) tablets, for oral use Initial U.S. Approval: 202520260323